| Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma GP Linette, EA Stadtmauer, MV Maus, AP Rapoport, BL Levine, L Emery, ... Blood 122 (6), 863-871, 2013 | 802 | 2013 |
| Antibody-modified T cells: CARs take the front seat for hematologic malignancies MV Maus, SA Grupp, DL Porter, CH June Blood 123 (17), 2625-2635, 2014 | 734 | 2014 |
| Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies GL Beatty, AR Haas, MV Maus, DA Torigian, MC Soulen, G Plesa, ... Cancer immunology research 2 (2), 112-120, 2014 | 599 | 2014 |
| CD8+ T-cell responses to adeno-associated virus capsid in humans F Mingozzi, MV Maus, DJ Hui, DE Sabatino, SL Murphy, JEJ Rasko, ... Nature medicine 13 (4), 419-422, 2007 | 591 | 2007 |
| A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ... Science translational medicine 9 (399), 2017 | 548 | 2017 |
| Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB MV Maus, AK Thomas, DGB Leonard, D Allman, K Addya, K Schlienger, ... Nature biotechnology 20 (2), 143-148, 2002 | 515 | 2002 |
| Chimeric antigen receptor T cells against CD19 for multiple myeloma AL Garfall, MV Maus, WT Hwang, SF Lacey, YD Mahnke, JJ Melenhorst, ... New England Journal of Medicine 373 (11), 1040-1047, 2015 | 480 | 2015 |
| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of Blood and Marrow Transplantation 25 (4), 625-638, 2019 | 477 | 2019 |
| T cells expressing chimeric antigen receptors can cause anaphylaxis in humans MV Maus, AR Haas, GL Beatty, SM Albelda, BL Levine, X Liu, Y Zhao, ... Cancer immunology research 1 (1), 26-31, 2013 | 402 | 2013 |
| Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma N Raje, J Berdeja, Y Lin, D Siegel, S Jagannath, D Madduri, M Liedtke, ... New England Journal of Medicine 380 (18), 1726-1737, 2019 | 386 | 2019 |
| Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells M Oelke, MV Maus, D Didiano, CH June, A Mackensen, JP Schneck Nature medicine 9 (5), 619-625, 2003 | 342 | 2003 |
| Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma LA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ... Science translational medicine 7 (275), 275ra22-275ra22, 2015 | 320 | 2015 |
| Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia JA Fraietta, KA Beckwith, PR Patel, M Ruella, Z Zheng, DM Barrett, ... Blood 127 (9), 1117-1127, 2016 | 257 | 2016 |
| Adoptive immunotherapy for cancer or viruses MV Maus, JA Fraietta, BL Levine, M Kalos, Y Zhao, CH June Annual review of immunology 32, 189-225, 2014 | 245 | 2014 |
| 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy H Zhang, KM Snyder, MM Suhoski, MV Maus, V Kapoor, CH June, ... The Journal of Immunology 179 (7), 4910-4918, 2007 | 201 | 2007 |
| Making better chimeric antigen receptors for adoptive T-cell therapy MV Maus, CH June Clinical Cancer Research 22 (8), 1875-1884, 2016 | 194 | 2016 |
| Chimeric antigen receptor T cell therapy: 25 years in the making S Gill, MV Maus, DL Porter Blood reviews 30 (3), 157-167, 2016 | 168 | 2016 |
| Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery L Tang, Y Zheng, MB Melo, L Mabardi, AP Castaņo, YQ Xie, N Li, ... Nature biotechnology 36 (8), 707-716, 2018 | 157 | 2018 |
| Ibrutinib treatment improves T cell number and function in CLL patients M Long, K Beckwith, P Do, BL Mundy, A Gordon, AM Lehman, ... The Journal of clinical investigation 127 (8), 3052-3064, 2017 | 156 | 2017 |
| Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors GC Pien, E Basner-Tschakarjan, DJ Hui, AN Mentlik, JD Finn, ... The Journal of clinical investigation 119 (6), 1688-1695, 2009 | 153 | 2009 |
